New imaging scan for pancreatic cancer before surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new imaging agent (68Ga-FAPI-46) to see if it can better show the extent of pancreatic cancer before surgery. It may help doctors plan your surgery more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You are in generally good health (able to care for yourself; out of bed more than half the day).
- You have pancreatic cancer that can be removed with surgery, or that has shrunk enough after chemotherapy to be removable.
- You are scheduled to have surgery to remove the tumor.
- You have had standard imaging tests (CT and MRI) as part of your pre-surgery workup.
- You are not pregnant or breastfeeding, and you are not severely anemic or have severely low blood counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging method called FAPI-PET to see if it can better detect pancreatic and bile duct cancers at an early stage. It may help doctors decide on the best treatment plan for you.
This study tests whether a special PET scan can better show how well chemotherapy given directly into the abdomen is working, compared to standard scans. This may help doctors see changes in tumors earlier and guide treatment.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This trial uses a special imaging scan called FAPI-PET to help doctors better diagnose pancreatic cancer. If you are suspected of having pancreatic cancer or a recurrence, this study may help confirm or clarify your diagnosis.
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.